Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RP103
RP103
Raptor to advance neurodegenerative disorder drug in registration study
Yahoo/Reuters
Thu, 12/10/15 - 11:36 am
Raptor Pharmaceutical
RP103
Huntington's disease
Raptor Pharmaceutical's Trial Failed, But Huntington's Disease Update Could Bring Gains At Year End
Yahoo/Benzinga
Tue, 09/15/15 - 11:40 am
Raptor Pharmaceutical
RP103
NASH
Huntington's disease
Raptor Pharma says may discontinue development of liver drug
Yahoo/Reuters
Mon, 09/14/15 - 08:23 am
Raptor Pharmaceutical
RP103
NASH
non-alcoholic fatty liver disease
Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Yahoo/Benzinga
Thu, 02/20/14 - 08:19 am
Raptor Pharmaceuticals
RP103
Huntington's disease
Why Raptor Could Run Up To Its PDUFA
Seeking Alpha
Tue, 02/12/13 - 10:59 am
Raptor Pharmaceuticals
Mylan
nephropathic cystinosis
RP103
Raptor Pharmaceuticals announces positive data on RP103 extension study
The Fly on the Wall
Mon, 11/5/12 - 11:02 am
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharma Rises as FDA Starts Drug Review
PharmPro
Sat, 06/16/12 - 01:52 pm
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis
Pipeline Review
Sat, 03/31/12 - 01:11 pm
Raptor Pharmaceuticals
RP103
nephropathic cystinosis
Raptor Pharmaceuticals Announces Positive Phase 3 Trial Results: Shares Tumble
Seeking Alpha
Sat, 07/30/11 - 10:21 am
Raptor Pharmaceuticals
RP103